HROW
HEALTHCAREHarrow Health Inc
AI Insight
What's Moving HROW Today?
No stock-specific AI insight has been generated for HROW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$28.54$54.85
$42.50
Fundamentals
Market Cap$1.6B
P/E Ratio—
EPS$-0.38
Dividend Yield—
Dividend / Share—
ROE-35.4%
Profit Margin-5.6%
Debt / Equity—
Trading
Volume640K
Avg Volume (10D)—
Shares Outstanding37.3M
HROW News
23 articles- GROW Small Cap Equity Fund Covered Its Position in Harrow (HROW) in Q1Yahoo Finance·Jun 23, 2026
- Is Harrow, Inc. (HROW) A Good Stock To Buy Now?Yahoo Finance·Jun 13, 2026
- Can Harrow’s (HROW) VERKAZIA Relaunch Redefine Its Niche Ophthalmic Strategy?Yahoo Finance·Jun 12, 2026
- Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric EyecareYahoo Finance·Jun 10, 2026
- What Does Cantor Fitzgerald Think About Harrow (HROW) After Cutting Its Price Target?Yahoo Finance·Jun 4, 2026
- Harrow (NASDAQ: HROW) posts June 2026 corporate investor presentationStock Titan·Jun 3, 2026
- Harrow to Present at William Blair’s 46th Annual Growth Stock ConferenceYahoo Finance·May 27, 2026
- Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 Losses - What's ChangedSimply Wall Street·May 25, 2026
- Why B.Riley Reduced Harrow, Inc. (HROW) Price Target Despite Long-Term OptimismYahoo Finance·May 20, 2026
- AppFolio And 2 Other High Growth Companies With Strong Insider OwnershipYahoo Finance·May 20, 2026
- Mark Baum Buys Handful Of Shares In HarrowYahoo Finance·May 17, 2026
- Why Harrow (HROW) Narrative Is Shifting As Analysts Recut Targets Yet Stay PositiveYahoo Finance·May 15, 2026
- The Harrow, Inc. (NASDAQ:HROW) First-Quarter Results Are Out And Analysts Have Published New ForecastsYahoo Finance·May 14, 2026
- Harrow Inc (HROW) Q1 2026 Earnings Call Highlights: Strong Product Demand Amid Revenue ChallengesYahoo Finance·May 12, 2026
- Harrow Q1 Earnings Call HighlightsMarketbeat·May 12, 2026
- Harrow Health, Inc. Q1 2026 Earnings Call SummaryMoby·May 12, 2026
- Harrow (HROW) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 11, 2026
- Harrow Announces First Quarter 2026 Financial ResultsYahoo Finance·May 11, 2026
- Is Harrow (HROW) Pricing Reflect Its 65.5% One Year Surge And DCF OutlookYahoo Finance·May 9, 2026
- Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 5, 2026
- Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out forYahoo Finance·May 4, 2026
- Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026Yahoo Finance·Apr 27, 2026
- Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030GlobeNewswire Inc.·Mar 24, 2026
All 23 articles loaded
Price Data
Open$42.16
Previous Close$42.41
Day High$43.58
Day Low$41.89
52 Week High$54.85
52 Week Low$28.54
52-Week Range
$28.54$54.85
$42.50
Fundamentals
Market Cap$1.6B
P/E Ratio—
EPS$-0.38
Dividend Yield—
Dividend / Share—
ROE-35.4%
Profit Margin-5.6%
Debt / Equity—
Trading
Volume640K
Avg Volume (10D)—
Shares Outstanding37.3M
About Harrow Health Inc
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—